# Abbott Laboratories (ABT) — Q4-2016 Earnings Results

**Report date:** 2017-01-25 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2016

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Up 0.0%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.65 | N/A | +1.25% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Management expressed a commitment to innovation and maintaining market position. However, they refrained from providing detailed future guidance.

**Key quotes:**

> Management highlighted ongoing efforts to enhance product offerings.

> They noted a stable demand environment but did not provide specific guidance.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported earnings that slightly exceeded expectations on EPS, but did not disclose revenue figures. The stock reaction was flat, indicating that investors may have anticipated the results or are waiting for more information. The lack of guidance could lead to uncertainty among investors about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2016_